Sancilio and Company Significantly Increases Its Capacity to Develop and Manufacture Prescription and Over-The-Counter Soft Gelatin Capsule Products with its New State-of-the-Art Manufacturing Line

Sancilio and Company, a leading developer and manufacturer of soft gelatin capsule products, recently launched its second high speed manufacturing line. SCI’s new line allows the company to respond to the ever-increasing demand for development and manufacturing of prescription and over-the-counter products in soft gelatin capsule form. SCI’s third high speed soft gelatin capsule manufacturing line is currently under construction and will be completed in early 2014.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

(PRWEB) January 09, 2013

Sancilio and Company (SCI), a leading developer and manufacturer of prescription and over-the-counter products in soft gelatin capsule form, proudly announces the recent addition of its second state-of–the-art soft gelatin capsule manufacturing line in Riviera Beach, Florida. The new soft gelatin capsule line combines SCI’s proprietary manufacturing processes with the most modern, state-of-the-art equipment. In addition to its Ocean Blue® Professional family of Omega-3 products, SCI is now well positioned to continue the growth of its soft gelatin capsule research and development projects, private label projects, international partnerships and other commercial endeavors.

SCI’s President and CEO, Dr. Fred Sancilio, states, “The addition of SCI’s new soft gelatin capsule manufacturing facility puts SCI at the forefront of the rapidly growing and valuable field of prescription and over-the-counter softgel products, not only in terms of research and development, but also in terms of commercial manufacturing and packaging.” Construction of SCI’s third soft gelatin capsule manufacturing line has begun and is expected to be completed by July 2013. SCI also manufactures tablet and oral liquid dosage forms of prescription and over-the-counter products.

In addition to its manufacturing facilities, SCI operates sophisticated analytical, development and scale-up laboratories in its Riviera Beach, Florida facility. SCI’s development laboratory specializes in lipid-based pharmaceutical products in soft gelatin dosage forms and can take projects from concept, through formulation development and clinical testing, up to NDA or ANDA filings. SCI’s analytical laboratory develops assays, conducts sophisticated stability studies and provides most of the resources needed in the Pharmaceutical Industry including: HPLC, GC, Mass Spectroscopy, dissolution testing and many other kinds of testing.

About SCI - Sancilio and Company, Inc. is a vertically integrated pharmaceutical company focused on the development, manufacture and sale of cardiovascular, dental and women's health products. SCI's products include Ocean Blue® Professional Omega-3 2100™, which contains 2,100 mg of Omega-3 per serving, chewable and liquid prescription sodium fluorides, and prescription prenatal vitamins. SCI's research and development labs and manufacturing facilities are all located in Riviera Beach, Florida.

Additional information about SCI can be found on the web at http://www.sancilio.com.


Contact

Follow us on: Contact's Facebook Contact's Twitter

Past News Releases Group Rss Subscribe